Its important to talk to doctors about B12 treatment plans
This is achieved, in part, by modulating the expression of pro-angiogenic factors such as Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor 2 (FGF-2)
Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
Under the experienced guidance of Dr
Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing
Aging Adults As metabolism naturally slows with age, 5-Amino-1MQ may help support healthier energy utilization and body composition